Inventor

Yechezkel Barenholz

Inventor
Jerusalem, IL

Overview

55→
Patents
1989–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 55 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations17%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests13%
C12NMicroorganisms or enzymes4%
Y10TTechnical subjects covered by former us classification4%
B09CReclamation of contaminated soil4%
F02BInternal-combustion piston engines4%
H05KPrinted circuits4%
A62DChemical means for extinguishing fires or for combating or protecting against harmful chemical agents3%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
11,123,293Liposomal formulation for joint lubrication202110,842,745Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same202010,722,599Lipid assemblies and uses thereof and some pH and electrostatic modulating lipids to be used in said assemblies202010,085,940Liposomes co-encapsulating a bisphosphonate and an amphipathic agent201810,052,387Ceramide reversal of multi-drug resistance201810,004,688Liposomal mupirocin20189,713,591'Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same'20179,078,812'Particulate drug carriers as desensitizing agents'20158,932,627'Liposomal compositions of glucocorticoid and glucocorticoid derivatives'20158,895,054'Methods for joint lubrication and cartilage wear prevention making use of glycerophospholipids'20148,871,276'Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents'20148,865,223'Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents'20148,673,285'Sphingoid polyalkylamine conjugates for vaccination'20148,242,089'Sphingolipids polyalkylamine conjugates for use in transfection'20128,062,662'Liposomes containing an entrapped compound in supersaturated solution'20117,985,417'Method of lipid structure preparation'20117,771,711'Sphingolipids\' polyalkylamines conjugates'20107,744,920'Use of liposomal glucocorticoids for treating inflammatory states'20107,357,944'Liposomal analgesic drug compositions prepared in GMV using an ammonium sulfate gradient'20087,160,554'Enhanced circulation effector composition and method'20077,150,882'Enhanced circulation effector composition and method'20067,122,668'Platinum complexes and their use in therapy'20067,056,653'Detection of binding of charged species using PH- or potential-sensitive probes'20067,029,680'Delivery of immunogenic molecules vis HBsAg particles'20066,926,905'Liposomak compositions and methods of preparation'20056,924,130'Enzymatic transesterification or hydrolysis of phospholipids in aqueous media'20056,787,132'Combined chemo-immunotherapy with liposomal drugs and cytokines'20046,696,080'Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient'20046,586,002'Enhanced circulation effector composition and method'20036,348,213'Method for reversing age-related changes in heart muscle cells'20026,326,353'Enhanced circulation effector composition and method'20016,235,308'Method of treating hypertension'20016,180,134'Enhanced ciruclation effector composition and method'20016,165,501'Radiation-protective phospholipid and method'20006,162,462'Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient'20006,156,337'Method for high loading of vesicles with biopolymeric substances'20006,066,331'Method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers'20005,948,756'Therapeutic lipoprotein compositions'19995,939,096'Liposome drug-loading method and composition'19995,919,480'Liposomal influenza vaccine composition and method'19995,914,311'Method for reducing serum lipoprotein (A) concentration'19995,817,856'Radiation-protective phospholipid and method'19985,741,514'Method for reducing serum lipoprotein(a) concentration'19985,622,715'Method of improving renal function'19975,593,508'Moist, absorbent material for cleaning articles and surfaces'19975,542,987'Method for cleaning the surfaces of a motor vehicle'19965,510,112'Composition for enhancing the biodegradation of biodegradable organic wastes'19965,401,413'Method for enhancing the biodegradation of biodegradable organic wastes'19955,376,183'Method for cleaning industrial and domestic articles and surfaces contaminated with organic or lipophilic wastes'19945,316,771'Method of amphiphatic drug loading in liposomes by ammonium ion gradient'19945,244,574'Method for treating oil spills on water'19935,043,166'Liposome/anthraquinone drug composition and method'19914,898,735'Liposome/doxorubicin composition and method'19904,812,314'Lipid replacement therapy'19894,797,285'Lipsome/anthraquinone drug composition and method'1989

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1989–2017Patents assigned to YISSUM RES DEV CO (39)· patent assignee history
1989–2021Based in Jerusalem, IL· patent location history
2000–2008Patents assigned to UNIV NEW YORK (4)· patent assignee history
2001Based in Jersusalem, IL· patent location history
2003–2011Patents assigned to ALZA CORP (4)· patent assignee history
2011–2018Patents assigned to BARENHOLZ YECHEZKEL (10)· patent assignee history
2018–2020Patents assigned to YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
YISSUM RES DEV CO391989–2017
BARENHOLZ YECHEZKELself102011–2018
ALZA CORP42003–2011
UNIV NEW YORK42000–2008
YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD42018–2020
Locations
LocationPatentsSpan
Jerusalem, IL541989–2021
Jersusalem, IL12001